Karnataka Endocrinology Institute Introduces Advanced HBOT Therapy for Diabetic Foot Care
The Karnataka Institute of Endocrinology and Research (KIER) has announced the launch of Hyperbaric Oxygen Therapy (HBOT) specifically for treating diabetic foot complications. This innovative move positions KIER as a pioneer in addressing a growing health concern among diabetic patients in the region.
Addressing a Critical Patient Need
KIER, an institution dedicated exclusively to diabetic care, reports receiving up to 120 patients every day who present with diabetic foot issues. This high volume underscores the urgent need for advanced treatment options. Diabetic foot ulcers, if left untreated, can lead to severe infections and even amputations, making timely and effective intervention crucial.
Pioneering Podiatry Department
The institute is recognized as one of the first in the area to establish a dedicated podiatry department. This specialized unit focuses on foot care for diabetic patients, providing comprehensive assessments and treatments. The introduction of HBOT therapy enhances this department's capabilities, offering a non-invasive treatment that involves breathing pure oxygen in a pressurized chamber to promote wound healing and fight infections.
Benefits of HBOT Therapy
HBOT therapy is known for its effectiveness in improving oxygen supply to damaged tissues, which can accelerate healing in diabetic foot ulcers. Key advantages include:
- Reduced risk of infections and complications
- Enhanced recovery times for chronic wounds
- Non-surgical approach to managing severe cases
This therapy is expected to significantly improve patient outcomes, potentially lowering amputation rates and improving quality of life for those affected.
Future Implications and Patient Care
By integrating HBOT into its treatment protocols, KIER aims to set a new standard in diabetic foot care. The initiative reflects a broader trend in healthcare towards adopting advanced technologies to tackle diabetes-related complications. Patients at the institute will now have access to a holistic care model that combines traditional treatments with cutting-edge therapies.
As diabetes prevalence continues to rise globally, such innovations are vital for managing associated health issues effectively. KIER's proactive approach may inspire other institutions to explore similar treatments, ultimately benefiting a wider patient population.
